Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Krystal Biotech, Inc. (KRYS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/07/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/07/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/26/2023 |
8-K
| Quarterly results |
| 07/18/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| ROSSI DINO A (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 07/03/2023 |
4
| Gangolli Julian S (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Granted 6,800 options to buy
@ $117.4, valued at
$798.3k
|
|
| 06/09/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 4,604 shares
@ $127.9578, valued at
$589.1k
Sold 1,073 shares
@ $129.0218, valued at
$138.4k
Sold 5,388 shares
@ $128.7335, valued at
$693.6k
Sold 5,000 shares
@ $127.958, valued at
$639.8k
Sold 10,000 shares
@ $127.9584, valued at
$1.3M
Sold 5,000 shares
@ $127.8612, valued at
$639.3k
Sold 3,935 shares
@ $129.2943, valued at
$508.8k
Sold 5,000 shares
@ $128.8375, valued at
$644.2k
Sold 10,000 shares
@ $128.5262, valued at
$1.3M
|
|
| 06/09/2023 |
4
| ORTH ANDREW C. (Chief Commercial Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 5,261 shares
@ $128.1045, valued at
$674k
Sold 6,906 shares
@ $128.9441, valued at
$890.5k
Sold 333 shares
@ $129.6972, valued at
$43.2k
Exercised 12,500 options to buy
@ $63.55, valued at
$794.4k
|
|
| 06/09/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
4
| Krishnan Suma (President, R&D) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 20,143 shares
@ $115.9757, valued at
$2.3M
Sold 4,557 shares
@ $116.8624, valued at
$532.5k
Sold 300 shares
@ $117.5733, valued at
$35.3k
Sold 18,884 shares
@ $115.995, valued at
$2.2M
Sold 5,716 shares
@ $116.9498, valued at
$668.5k
Sold 400 shares
@ $117.605, valued at
$47k
|
|
| 06/02/2023 |
4
| Krishnan Krish S (President and CEO) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 18,884 shares
@ $115.995, valued at
$2.2M
Sold 5,716 shares
@ $116.9498, valued at
$668.5k
Sold 400 shares
@ $117.605, valued at
$47k
Sold 20,143 shares
@ $115.9757, valued at
$2.3M
Sold 4,557 shares
@ $116.8624, valued at
$532.5k
Sold 300 shares
@ $117.5733, valued at
$35.3k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/23/2023 |
4
| Romano Kathryn (Chief Accounting Officer) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 12,500 shares
@ $95.05, valued at
$1.2M
Sold 12,500 shares
@ $95.0449, valued at
$1.2M
Sold 3,428 shares
@ $95.0808, valued at
$325.9k
Sold 2,521 shares
@ $105.8036, valued at
$266.7k
Sold 2,570 shares
@ $106.8087, valued at
$274.5k
Sold 1,300 shares
@ $107.8777, valued at
$140.2k
Sold 2,955 shares
@ $109.1719, valued at
$322.6k
Sold 3,154 shares
@ $109.9933, valued at
$346.9k
Sold 12,500 shares
@ $110, valued at
$1.4M
Exercised 12,500 options to buy
@ $52.26, valued at
$653.3k
Exercised 12,500 options to buy
@ $52.26, valued at
$653.3k
|
|
| 05/23/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 50,000 shares
@ $95.0237, valued at
$4.8M
|
|
| 05/19/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
4
| JANNEY DANIEL (Director) has filed a Form 4 on Krystal Biotech, Inc.|
Txns:
| Sold 17,100 shares
@ $90.7356, valued at
$1.6M
|
|
| 05/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/10/2023 |
SC 13G/A
| FMR LLC reports a 10.1% stake in KRYSTAL BIOTECH INC |
|
|
|